Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy.
Saved in:
| Title: | Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy. |
|---|---|
| Authors: | Li ZD; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China., Ren TY, Wang YS, Bi Z |
| Source: | International journal of surgery (London, England) [Int J Surg] 2026 Feb 01; Vol. 112 (2), pp. 2243-2245. Date of Electronic Publication: 2025 Nov 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101228232 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1743-9159 (Electronic) Linking ISSN: 17439159 NLM ISO Abbreviation: Int J Surg Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41208790 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+ZD%22">Li ZD</searchLink>; Breast Cancer Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Ren+TY%22">Ren TY</searchLink><br /><searchLink fieldCode="AU" term="%22Wang+YS%22">Wang YS</searchLink><br /><searchLink fieldCode="AU" term="%22Bi+Z%22">Bi Z</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101228232%22">International journal of surgery (London, England)</searchLink> [Int J Surg] 2026 Feb 01; Vol. 112 (2), pp. 2243-2245. <i>Date of Electronic Publication: </i>2025 Nov 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101228232 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1743-9159 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217439159%22">17439159 </searchLink><i>NLM ISO Abbreviation: </i>Int J Surg <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41208790 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/JS9.0000000000003621 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2243 Titles: – TitleFull: Whether adjuvant immunotherapy should continue to be used in patients with triple-negative breast cancer who respond to neoadjuvant immunotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li ZD – PersonEntity: Name: NameFull: Ren TY – PersonEntity: Name: NameFull: Wang YS – PersonEntity: Name: NameFull: Bi Z IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2026 Feb 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1743-9159 Numbering: – Type: volume Value: 112 – Type: issue Value: 2 Titles: – TitleFull: International journal of surgery (London, England) Type: main |
| ResultId | 1 |
